Secukinumab-Induced Bullous Pemphigoid: A Case Report
Background: Drug-induced bullous pemphigoid is a rare cutaneous adverse reaction linked to various systemic medications. Secukinumab, an interleukin-17A inhibitor widely used for moderate-to-severe psoriasis, has rarely been implicated in the development of bullous pemphigoid. Case Presentation: A 79-year-old male with...